Dr Reddys Laboratories Stock Alpha and Beta Analysis
| RDY Stock | USD 13.60 0.39 2.79% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Dr Reddys Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in Dr Reddys over a specified time horizon. Remember, high Dr Reddys' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Dr Reddys' market risk premium analysis include:
Beta 0.32 | Alpha (0.16) | Risk 1.57 | Sharpe Ratio (0.03) | Expected Return (0.05) |
Dr Reddys Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
RDY |
Dr Reddys Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Dr Reddys market risk premium is the additional return an investor will receive from holding Dr Reddys long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Dr Reddys. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Dr Reddys' performance over market.| α | -0.16 | β | 0.32 |
Dr Reddys expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Dr Reddys' Buy-and-hold return. Our buy-and-hold chart shows how Dr Reddys performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Dr Reddys Market Price Analysis
Market price analysis indicators help investors to evaluate how Dr Reddys stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dr Reddys shares will generate the highest return on investment. By understating and applying Dr Reddys stock market price indicators, traders can identify Dr Reddys position entry and exit signals to maximize returns.
Dr Reddys Return and Market Media
The median price of Dr Reddys for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 is 14.46 with a coefficient of variation of 4.65. The daily time series for the period is distributed with a sample standard deviation of 0.68, arithmetic mean of 14.57, and mean deviation of 0.57. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc. | 01/13/2025 |
2 | Morton Capital Management LLC CA Sells 158 Shares of Abbott Laboratories | 01/17/2025 |
3 | Does Abbott Laboratories Deserve A Spot On Your Watchlist | 02/05/2025 |
4 | Cornerstone Planning Group LLC Reduces Stock Holdings in Abbott Laboratories | 02/10/2025 |
5 | Essex Financial Services Inc. Purchases 118 Shares of Abbott Laboratories | 02/11/2025 |
6 | Immuno-Biological Laboratories Third Quarter 2025 Earnings EPS JP6.66 | 02/12/2025 |
7 | Bio-Rad Laboratories to Acquire Stilla Technologies Expanding Digital PCR Capabilities | 02/13/2025 |
8 | If You Invested 10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now | 02/14/2025 |
About Dr Reddys Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including RDY or other stocks. Alpha measures the amount that position in Dr Reddys Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.0319 | 0.0287 | 0.0271 | Price To Sales Ratio | 0.75 | 0.86 | 0.7 |
Dr Reddys Upcoming Company Events
As portrayed in its financial statements, the presentation of Dr Reddys' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dr Reddys' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Dr Reddys' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Dr Reddys. Please utilize our Beneish M Score to check the likelihood of Dr Reddys' management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Dr Reddys
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.